Vertex Pharmaceuticals (VRTX) stock
Stock · prices in USD
Next quarterly results
Estimated around Feb 11, 2027 (in 89 days)
Estimated from the company's previous report dates; the official date is announced by the company.
Is it growing?
Revenue from SEC filings · fiscal 2022–2025
Does it make money?
Margins, cash and debt from SEC filings
Price ÷ diluted earnings per share of the last 4 quarters to Sep 30, 2026 (SEC filing of Nov 3, 2026). Price as of Nov 14, 2026, 19:50 UTC. A descriptive ratio: it does not say whether a stock is worth buying, and one-off or restated earnings can distort it.
Source: filings submitted to the SEC (EDGAR) and delayed market data. Errors or delays are possible; results dates are estimates. Educational only.
Price facts
Latest delayed quote: $538.60, -1.04% versus the previous close (checked at 19:50 UTC on Nov 14, 2026).
Last close: $547.09 on Nov 6, 2026.
52-week closing range: $409.47 to $558.88. The last close sits 92% of the way from the low to the high.
Change over
Recent 3-month volatility is within its usual range compared with its own history since 2021 (62nd percentile).
Delayed data. Past moves do not indicate future results.
Create a free account and get 3 AI analyses: reaction zones, macro scenarios and your timeframe.
Try GeekAlpha free: 3 analyses, no cardYou're signed in. Open the app to analyze VRTX.
Open the appGo further on VRTX
Support and resistance reaction zones for VRTX: areas where price reacted before. Reference points, not destinations.
Unlock with your free analysisScenarios for VRTX around upcoming macro events, such as central bank meetings and inflation data.
Unlock with your free analysisThe analysis on the timeframe you choose, from intraday to long term.
Unlock with your free analysis
What happened
- Automated summary of the day's move ·
Down 4.1% on the day. The move was 1.12 times its typical volatility.